Joint Formulary & PAD

Foslevodopa with foscarbidopa - Parkinson's disease

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Red
Formulations :
  • Intravenous infusion
Associated Icons :
BNF SPC
NHSE
Restrictions / Comments :
Important
Will need tertiary centre approval before Blueteq/funding released

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Foslevodopa with foscarbidopa
Indication :
Parkinson's disease
Group Name :
Keywords :
Brand Names Include :
Produodopa
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0

Other Indications

Below are listed other indications that Foslevodopa with foscarbidopa is used to treat.

  • No records returned.

Committee Recommendations (1)

19 Mar 24 - Not Set

This drug falls under the responsibility of NHS England Specialised Commissioning and should therefore not be prescribed in Primary Care.

Clinicians / specialists within the Acute setting should only prescribe in line with their Trust formulary / pharmacy advice.

GPs should ensure that patient medication records include any medicine for which prescribing remains the responsibility of secondary or tertiary care. This will ensure that GP records, which are accessed by other healthcare providers, are a true and accurate reflection of the patient’s medication.